RxSaludable Review
Best for: Spanish-speaking patients who want compounded GLP-1 care from Spanish-speaking providers
RxSaludable is a Spanish-language GLP-1 weight-loss telehealth service (atencion en espanol) offering compounded semaglutide from $99 the first month ($179/mo after) and tirzepatide from $189 the first month, prescribed by U.S.-licensed, Spanish-speaking providers and shipped free. Pricing is the same at every dose with no membership fee; the brand also offers microdose GLP-1, sermorelin, NAD+ and glutathione.
then $179/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
RxSaludable is a solid telehealth option with balanced features and pricing.
How we scored RxSaludable
Each dimension is scored algorithmically from RxSaludable’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $179/mo, RxSaludable runs about 5% above the $170 median for GLP-1 providers, and the first-month promo drops to $99. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10RxSaludable offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.8/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-18).
Accessibility10%
6.5/10RxSaludable's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.3/10RxSaludable provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this RxSaludable review
Last checked 2026-06-18- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications RxSaludable offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded Semaglutide | compounded | $99 |
| Compounded Tirzepatide | compounded | $189 |
What we like
- Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
- Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
- LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
- Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime
Watch-outs
- Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
- Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
- No legal entity name or explicit state-coverage list published on the site
- Compounded GLP-1s are not FDA-approved (the site discloses this)
Is RxSaludable worth it? Our verdict
RxSaludable positions itself around one thing: Spanish-speaking patients who want compounded GLP-1 care from Spanish-speaking providers. New patients start at $99 in month one, but the price settles at $179/month after that — so the headline is a trial offer, not the standing rate. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
How much RxSaludable actually costs
- Compounded semaglutide — $99 first month, then $179/month
- Compounded tirzepatide — $189 first month, then $269/month
That's roughly in line with the ~$170/month median across the GLP-1 providers we track.
Medications: what RxSaludable prescribes
RxSaludable prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who RxSaludable is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
RxSaludable is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $99 intro price steps up to $179/month. Use the first month to confirm the medication works for you, then re-check the ongoing math before you settle in.
Ready to start with RxSaludable?
Starting at $99/month. See current pricing and start your free consultation.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this RxSaludable review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to RxSaludable
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with RxSaludable?
Starting at $99/month. See current pricing and start your free consultation.